Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
This article is a result of their own long-term observation of the patient treatment of inoperable cancer of the kidney. As first-line therapy pazopanib is used in standard dosage. The drug belongs to the new generation of drugs that block angiogenesis and having cytoreductive effect. During treatme...
Main Authors: | A A Klimenko, S A Ivanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2013-12-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/view/26927 |
Similar Items
-
Axitinib in the successive targeted therapy of patients with metastatic kidney cancer
by: B. Ya. Alekseev, et al.
Published: (2014-11-01) -
Axitinib in the successive targeted therapy of patients with metastatic kidney cancer
by: B. Ya. Alekseev, et al.
Published: (2014-11-01) -
Clinical economic assessment of the use of pazopanib in the therapy of disseminated kidney cancer
by: S. K. Zyryanov, et al.
Published: (2016-05-01) -
Pazopanib as first-line therapy for patients with metastatic kidney cancer
by: B. Ya. Alekseev, et al.
Published: (2018-07-01) -
Consecutive targeted therapy in patients with metastatic kidney cancer
by: А. S. Kalpinskiy, et al.
Published: (2015-12-01)